C
Corix Bioscience, Inc. (CXBS)
PNK – Real Time Price. Currency in USD
0.00
0.00 (0.00%)
At close: Sep 9, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
PNK – Real Time Price. Currency in USD
0.00
0.00 (0.00%)
At close: Sep 9, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Total debt $5.2M significantly exceeds cash reserves ($2.2K), raising financial stability concerns
Total current liabilities $1.1M surpass Total current assets $4.6K, signaling liquidity issues
Debt-to-equity ratio (0.9) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-10.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$1.9M limits the company's ability to reinvest or pay down debt
| METRIC | 2013 (Jan 2014) | 2014 (Jan 2015) | 2015 | 2016 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 694K | 694K |
| Gross Profit | N/A | N/A | -372K | 537K | 537K |
| Operating Income | -27K | -57K | -3M | -4M | -4M |
| Net Income | -2M | -57K | -3M | -4M | -4M |
| EBITDA | -27K | -54K | -3M | -4M | -4M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Y/Y | N/A | N/A | N/A | N/A | 1.0 |
| 3y average | 999 | -1567.92 | N/A | N/A | 3.3 |
| 5y average | 999 | -1366.06 | N/A | N/A | 3.3 |
| Weighted average score | 2.2 | ||||
DCF model data has not been calculated yet.
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | 2.56 | 1.0 |
| Payout ratio | 0.00 | 33.71 | 1.0 |
| 5-year dividend growth rate | N/A | 8.25 | 1.0 |
| Years of dividend increase | N/A | 1.00 | 1.0 |
| Weighted average score | 1.0 | ||
Fair Value data has not been calculated yet.
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |